Stay updated on Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.

Latest updates to the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedPage now displays a recruitment status indicating no longer looking for participants and adds new reader guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) to help users understand and engage with the study. The Intervention/Treatment label is reformatted, and the site revision is updated to v3.6.0.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a new published iteration of the page.SummaryDifference0.1%

- Check28 days agoChange DetectedThe footer branding and sponsor-related navigation text on the study page has been removed, changing how institutional affiliation and related links are presented at the bottom of the page.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a new revision label, updating from v3.5.3 to v3.5.4. This indicates an underlying platform or template update without altering the study details.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page's revision label was updated from v3.5.2 to v3.5.3, indicating a minor update to the page template. This update does not alter the study details or data presented on the page.SummaryDifference0.1%

- Check71 days agoChange DetectedChangelog updated with Revision: v3.5.2 added and Revision: v3.5.0 removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.